Beck Bode’s Definium Therapeutics DFTX Stock Holding History
Bought
Maintained
Sold
Other funds holding DFTX
Beck Bode's DFTX Position: Q3 2026 in Review
Beck Bode held its Definium Therapeutics (DFTX) position steady in Q3 2026 at 5,939 shares worth $226K. The position accounts for 0.04% of the portfolio, ranked #89.
Beck Bode first reported a position in DFTX in Q2 2026 and has held it in 2 quarters since. The position peaked at $279K in Q2 2026. 253 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.
- Beck Bode held 5,939 shares of Definium Therapeutics worth $226K as of Q3 2026.
- Beck Bode left its Definium Therapeutics share count unchanged in Q3 2026.
- Definium Therapeutics made up 0.04% of Beck Bode's portfolio in Q3 2026, its #89 holding.
- Beck Bode first reported a position in Definium Therapeutics in Q2 2026 and has held it in 2 quarters since.
- Beck Bode's Definium Therapeutics position peaked at $279K in Q2 2026.
- 253 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.
Based on Beck Bode's 13F filing for Q3 2026, filed 12 Nov 2026.